Pregnancy-Associated Severe Sepsis: Contemporary State and Future Challenges

被引:19
作者
Oud L. [1 ]
机构
[1] Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX
关键词
Intensive care unit; Mortality; Pregnancy; Resource utilization; Resuscitation; Severe sepsis;
D O I
10.1007/s40121-014-0037-7
中图分类号
学科分类号
摘要
Pregnancy is associated with an increased risk of infection related to its associated mechanical and physiological changes. Sepsis remains among the top causes of maternal death worldwide and is associated with substantial maternal morbidity. However, there are sparse data on pregnancy-associated severe sepsis (PASS), related in part to infrequent reports, varying case definitions and methodological approach, small cohort size, and often limited focus on severe sepsis in selected phases of pregnancy outcomes. Available reports vary, but indicate that PASS is a rare but likely increasing complication, and it is more likely to develop with increased maternal age, among minority women, the poor, those lacking health insurance, those with chronic illness or pregnancy-associated complications, and following invasive procedures. Obstetric sites of infection are the most prevalent, but non-obstetric infections often underlie pregnancy-associated severe sepsis, though the source of infection is often not readily apparent during initial care. Women with PASS can have a rapidly fatal course and require heightened clinician vigilance for early diagnosis and timely effective intervention. Nevertheless, available reports raise concerns about prevalent substandard care of these patients, contributing to adverse outcomes. The case fatality of PASS appears lower than that in the general population with severe sepsis, while the long-term outcomes of survivors remain unknown. © 2014, The Author(s).
引用
收藏
页码:175 / 189
页数:14
相关论文
共 44 条
  • [1] Bone R.C., Balk R.A., Cerra F.B., Et al., Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, Chest, 101, pp. 1644-1655, (1992)
  • [2] Levy M.M., Fink M.P., Marshall J.C., Et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, Crit Care Med, 31, pp. 1250-1256, (2003)
  • [3] Martin G.S., Mannino D.M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000, N Engl J Med, 348, pp. 1546-1554, (2003)
  • [4] Kumar G., Kumar N., Taneja A., Et al., Nationwide trends of severe sepsis in the 21st century (2000–2007), Chest, 140, pp. 1223-1231, (2011)
  • [5] Lagu T., Rothberg M.B., Shieh M., Et al., Hospitalizations, costs and outcomes of severe sepsis in the United States 2003–2007, Crit Care Med, 40, pp. 754-761, (2012)
  • [6] Adhikari N.K., Fowler R.A., Bhagwanjee S., Et al., Critical care and the global burden of critical illness in adults, Lancet, 138, pp. 1339-1346, (2010)
  • [7] Angus D.C., Linde-Zwirble W.T., Lidicker J., Et al., Epidemiology of severe sepsis in the United States: analysis of incidence, outcomes, and associated costs of care, Crit Care Med, 29, pp. 1303-1310, (2001)
  • [8] Winters B.D., Eberlein M., Leung J., Et al., Long-term mortality and quality of life in sepsis: a systematic review, Crit Care Med, 38, pp. 1276-1283, (2010)
  • [9] Barnato A.E., Alexander S.L., Linde-Zwirble W.T., Angus D.C., Racial variation in the incidence, care, and outcomes of severe sepsis, Am J Respir Crit Care Med, 177, pp. 279-284, (2008)
  • [10] Melamed A., Sorvillo F.J., The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data, Crit Care, 13, (2009)